Privacy, property, and the family in the age of genetic testing: Observations from transformative feminism Read more about Privacy, property, and the family in the age of genetic testing: Observations from transformative feminism
Designing an optimal intellectual property system for plants: A U.S. Supreme Court debate Read more about Designing an optimal intellectual property system for plants: A U.S. Supreme Court debate
Comment: DNA as property: Implications on the constitutionality of DNA dragnets Read more about Comment: DNA as property: Implications on the constitutionality of DNA dragnets
The social life of genes: Privacy, property and the new genetics Read more about The social life of genes: Privacy, property and the new genetics
Response to Rich's letter regarding "the social life of genes: Privacy, property and the new genetics" Read more about Response to Rich's letter regarding "the social life of genes: Privacy, property and the new genetics"
Public access versus proprietary rights in genomic information: What is the proper role of intellectual property rights? Read more about Public access versus proprietary rights in genomic information: What is the proper role of intellectual property rights?
Navigating uncharted waters: Intellectual property rights surrounding genomics research and development information Read more about Navigating uncharted waters: Intellectual property rights surrounding genomics research and development information
Is policy towards intellectual property rights addressing the real problems? The case of unauthorized appropriation of genetic resources Read more about Is policy towards intellectual property rights addressing the real problems? The case of unauthorized appropriation of genetic resources
Beyond blue gene: Intellectual property and bioinformatics Read more about Beyond blue gene: Intellectual property and bioinformatics
The dilemma of intellectual property rights for pharmaceuticals: The tension between ensuring access of the poor to medicines and committing to international agreements Read more about The dilemma of intellectual property rights for pharmaceuticals: The tension between ensuring access of the poor to medicines and committing to international agreements
